2Leung DA;Goin JE;Sickles C.Determinants of postembolization syndrome after hepatic chemoembolization[J],2001(03).
3Jeon SH;Park KS;Kim YH.Incidence and risk factors of acute hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma,2007(03).
5Castells A;Bruix J;Ayuso C.Transarterial embolization for hepatocellular carcinoma.Antibiotic prophylaxis and clinical meaning of postembolization fever[J],1995(04).
6Wigmore SJ.Postchemoembolisation syndrome:tumour necrosis or hepatocyte injury[J],2003(08).
7Chung JW;Park JH;Han JK.Hepatic tumors:predisposing factors for complications of transcatheter oily chemoembolization,1996(01).
8Barone M, Ettorre GC, Ladisa R, et al. Transcatheter arterial chemoembolization (TACE) in treatment of hepatocellular carcinoma. Hepatogastroenterology, 2003, 50:183-187.
9Caturelli E, Siena DA, Fusilli S,et al.Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of damage to nontumorous liver tissue-long-term prospective study. Radiology, 2000, 215:123-128.
10Sakamoto I, Iwanaga S, Nagaoki K,et al. Intrahepatic biloma formation (bile duct necrosis) after transcatheter arterial chemoembolization. AJR Am J Rentgenol, 2003, 181:79-87.
9Jeon SH, Park KS, Kim YH, et al. Incidence and risk factors of acute hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma [ J ]. Korean J Gastroenterol, 2007, 50 (3) :176-182.
10Morante A, Romano M, Cuomo A, et al. Massive gastric ulceration after transarterial chemoembolization for hepatocellular carcinoma [ J ]. Gastrointest Endosc, 2006, 63 (4) :718-720.
